Clinical relevance of kras mutation detection in metastatic colorectal cancer treated by cetuximala plus chemotherapy

被引：0
|
作者：
Di fiore, Frederic
Le pessot, Florence
Blanchard, France
Charbonnier, Francoise
Lamy, Aude
Frebourg, Thierry
Michel, Pierre
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A433 / A433
页数：1
相关论文
共 50 条
  • [31] Molecular targeting in colorectal cancer and the role of KRAS mutation testing in the management of metastatic colorectal cancer
    McIntire, Maria G.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S22 - S22
  • [32] Kras in metastatic colorectal cancer
    Wicki, Andreas
    Herrmann, Richard
    Christofori, Gerhard
    SWISS MEDICAL WEEKLY, 2010, 140 : 14 - 19
  • [33] KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
    Radanova, Maria
    Mihaylova, Galya
    St Stoyanov, George
    Draganova, Vyara
    Zlatarov, Aleksandar
    Kolev, Nikola
    Dimitrova, Eleonora
    Conev, Nikolay
    Ivanova, Diana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [34] KRAS mutation testing of metastatic colorectal cancer in Australia: Where are we at?
    Scott, Rodney J.
    Fox, Stephen B.
    Desai, Jayesh
    Grieu, Fabienne
    Amanuel, Benhur
    Garrett, Kerryn
    Harraway, James
    Cheetham, Glenice
    Pattle, Neville
    Haddad, Afaf
    Byron, Keith
    Rudzki, Barney
    Waring, Paul
    Iacopetta, Barry
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 261 - 265
  • [35] GENETIC ANALYSIS OF KRAS MUTATION STATUS IN METASTATIC COLORECTAL CANCER PATIENTS
    Zavodna, K.
    Konecny, M.
    Spanik, S.
    Galbavy, S.
    Vizvaryova, M.
    Weismanova, E.
    Kausitz, J.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4015 - 4016
  • [36] Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
    Ucar, Gokhan
    Ergun, Yakup
    Esen, Selin Akturk
    Acikgoz, Yusuf
    Dirikoc, Merve
    Esen, Irfan
    Bal, Oznur
    Uncu, Dogan
    MEDICINE, 2020, 99 (39) : E22407
  • [37] The Role of KRAS Mutation Testing in the Management of Patients With Metastatic Colorectal Cancer
    Monzon, Federico A.
    Ogino, Shuji
    Hammond, M. Elizabeth H.
    Halling, Kevin C.
    Bloom, Kenneth J.
    Nikiforova, Marina N.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2009, 133 (10) : 1600 - 1606
  • [38] Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients
    Zavodna, K.
    Konecny, M.
    Krivulcik, T.
    Spanik, S.
    Behulova, R.
    Vizvaryova, M.
    Weismanova, E.
    Galbavy, S.
    Kausitz, J.
    NEOPLASMA, 2009, 56 (03) : 275 - 278
  • [39] Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients
    Vincenzi, B.
    Cremolini, C.
    Sartore-Bianchi, A.
    Russo, A.
    Mannavola, F.
    Perrone, G.
    Pantano, F.
    Loupakis, F.
    Rossini, D.
    Ongaro, E.
    Bonazzina, E.
    Zoccoli, A.
    De Maglio, G.
    Fontanini, G.
    Falcone, A.
    Santini, D.
    Onetti-Muda, A.
    Siena, S.
    Tonini, G.
    Aprile, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 38 - 38
  • [40] KRAS mutation is highly predictive of cetuximab resistance in metastatic colorectal cancer
    Di Fiore, F.
    Le Pessot, F.
    Lamy, A.
    Charbonnier, F.
    Sabourin, J.
    Paillot, B.
    Frebourg, T.
    Michel, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345